Recursion: Nvidia Sells Out, Collaboration Still Alive, Data Ahead (NASDAQ:RXRX)
Seeking Alpha·2026-03-02 21:32Recursion Pharmaceuticals ( RXRX ) stock hasn't had a strong start to 2026, with the name down over 12% year-to-date and Nvidia Corporation ( NVDA ) selling its position in the stock. My previous article on RXRX in January ratedScientist and trader of biotech stock. Focus on trading around events such as trial results and NDA/BLA approvals. Also covering companies in industries regulated by the FDA. Articles present my opinion on stocks, but don't constitute investment advice.Analyst’s Disclosure: I/we have ...